Management of women who test positive for high-risk types of human papillomavirus: the HART study
Top Cited Papers
- 1 December 2003
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 362 (9399) , 1871-1876
- https://doi.org/10.1016/s0140-6736(03)14955-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Human Papillomavirus DNA Testing for Cervical Cancer Screening in Low-Resource SettingsJNCI Journal of the National Cancer Institute, 2000
- HPV DNA Testing in Cervical Cancer ScreeningJAMA, 2000
- HPV DNA Testing of Self-collected Vaginal Samples Compared With Cytologic Screening to Detect Cervical CancerJAMA, 2000
- Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe.BJOG: An International Journal of Obstetrics and Gynaecology, 2000
- HPV testing in primary screening of older womenBritish Journal of Cancer, 1999
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999
- Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 womenBritish Journal of Cancer, 1999
- Screening for cervical intraepithelial neoplasia grade 2/3: Validity of cytologic study, cervicography, and human papillomavirus detectionAmerican Journal of Obstetrics and Gynecology, 1996
- Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancerBritish Journal of Cancer, 1996
- Human papillomavirus testing in primary cervical screeningThe Lancet, 1995